ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,699.60
      -2.08%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.21
      0.19%
      Bitcoin
      57,323.18
      -0.75%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Intellia Therapeutics Inc (NTLA)

      7. Intellia Therapeutics Inc (NTLA) Financials

      Intellia Therapeutics Inc

      Intellia Therapeutics Inc (NTLA)

      24.64
      1.49
      (6.44%)
      At close: July 11 4:00PM
      Delayed by 15 minutes
      24.63
      -0.01
      ( -0.04% )
      After Hours: 4:00PM
      Delayed by 15 minutes

      Intellia Therapeutics Inc Financial Summary

      The current NTLA market cap is 2.38B. The company's latest EPS is USD -4.9877 and P/E is -4.94.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 12.61M13.59M11.99M-1.92M28.94M
      Operating Income -115.01M-136.33M-134.96M-144.62M-114M
      Net Income -103.13M-123.68M-122.22M-132.16M-107.44M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 43.1M57.99M33.05M52.12M36.28M
      Operating Income -106.37M-136.58M-269.18M-469.24M-530.92M
      Net Income -99.53M-134.23M-267.89M-474.19M-481.19M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.42B1.32B1.24B1.3B1.26B
      Total Liabilities 227.05M218.35M205.94M250.81M223.45M
      Total Equity 1.19B1.1B1.04B1.05B1.04B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 334.28M676.32M1.29B1.52B1.3B
      Total Liabilities 64.4M149.25M254.22M284.53M250.81M
      Total Equity 269.88M527.07M1.04B1.24B1.05B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -109.33M-199.65M-301.03M-394.09M-120.66M
      Investing -122.25M-156.79M-77.29M-31.35M5.9M
      Financing 2.22M4.74M23.84M130.32M59.99M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -103.24M-49.91M-225.03M-333.29M-394.09M
      Investing 25.18M-214.49M-550.78M160.31M-31.35M
      Financing 76.43M371.78M736.69M582.96M130.32M

      Stats and Ratios

      Market Cap 2.38B
      Price to Earnings Ratio -4.94
      Price to Sales Ratio 65.56
      Price to Cash Ratio 10.49
      Price to Book Ratio 2.26
      Dividend Yield -

      Share Statistics

      Shares Outstanding 96.48M
      Average Volume (1 week) 1.43M
      Average Volume (1 Month) 1.76M
      52 Week Change -42.63%
      52 Week High 46.50
      52 Week Low 19.37
      Spread (Intraday) 0.5 (2%)

      Company Info

      Company Name Intellia Therapeutics Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.intelliatx.com
      Industry in vitro,in vivo diagnostics (2835)